Eupraxia Pharmaceuticals INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Joseph S. Freedman increased his beneficial ownership in Eupraxia Pharmaceuticals Inc. to 9.0% through recent share purchases and warrant exercises.
NASDAQ
SCHEDULE: Freedman Boosts Eupraxia Stake to 10.2%
Joseph S. Freedman increased his beneficial ownership in Eupraxia Pharmaceuticals Inc. to 10.2% after purchasing 543,130 common shares in a recent public offering.